Back to results
US 2017/0362598 A1Published application
Anticancer therapeutic intervention
AssigneePhyzat Biopharmaceuticals, Lda.
InventorPatricio Soares da Silva
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method of treating cancer using interfering RNA duplexes to mediate gene silencing. The present invention is also directed to interfering RNA duplexes and vectors encoding such interfering RNA duplexes.
Claims20
An siNA (short interfering nucleic acid) molecule, wherein said molecule targets at least one sequence selected from SEQ ID NO:
- 1-SEQ ID NO:
- 104 and SEQ ID NO:
- 209-SEQ ID NO:
- 297 or a variant thereof or at least one sequence complementary to a sequence selected from SEQ ID NO:
- 1-SEQ ID NO:
- 104 and SEQ ID NO:
- 209-SEQ ID NO:
- 297 or a variant thereof for use as a medicament.
5 more elements
Dependencies are inferred from the claim text.